See more : Hastings Technology Metals Limited (HSRMF) Income Statement Analysis – Financial Results
Complete financial analysis of ReWalk Robotics Ltd. (RWLK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ReWalk Robotics Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
- Pagero Group Ab (Publ) (PAGERO.ST) Income Statement Analysis – Financial Results
- Auckland International Airport Limited (ACKDF) Income Statement Analysis – Financial Results
- Hamilton Lane Incorporated (HLNE) Income Statement Analysis – Financial Results
- ZF Commercial Vehicle Control Systems India Limited (ZFCVINDIA.BO) Income Statement Analysis – Financial Results
- Happy Belly Food Group Inc. (HBFG.CN) Income Statement Analysis – Financial Results
ReWalk Robotics Ltd. (RWLK)
About ReWalk Robotics Ltd.
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 13.85M | 5.51M | 5.97M | 4.39M | 4.87M | 6.55M | 7.75M | 5.87M |
| Cost of Revenue | 9.40M | 3.61M | 3.06M | 2.20M | 2.15M | 3.72M | 4.65M | 5.13M |
| Gross Profit | 4.45M | 1.91M | 2.90M | 2.19M | 2.73M | 2.83M | 3.10M | 736.00K |
| Gross Profit Ratio | 32.14% | 34.57% | 48.66% | 49.83% | 55.94% | 43.16% | 40.00% | 12.54% |
| Research & Development | 4.15M | 4.03M | 2.94M | 3.46M | 5.35M | 7.35M | 6.04M | 9.03M |
| General & Administrative | 10.00M | 7.13M | 5.63M | 4.98M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 13.92M | 9.84M | 6.99M | 5.75M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 23.92M | 16.98M | 12.62M | 10.73M | 11.43M | 14.69M | 19.05M | 22.15M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 28.07M | 21.01M | 15.56M | 14.19M | 16.77M | 22.04M | 25.09M | 31.18M |
| Cost & Expenses | 37.47M | 24.61M | 18.62M | 16.40M | 18.92M | 25.76M | 29.75M | 36.31M |
| Interest Income | 1.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.00 |
| Interest Expense | 20.00K | 22.00K | 25.00K | 907.00K | 1.53M | 2.42M | 2.48M | 2.01M |
| Depreciation & Amortization | 1.85M | 202.00K | 266.00K | 285.00K | 321.00K | 463.00K | 642.00K | 696.00K |
| EBITDA | -21.77M | -18.90M | -12.39M | -11.73M | -13.72M | -18.79M | -21.48M | -29.79M |
| EBITDA Ratio | -157.10% | -343.35% | -208.30% | -267.29% | -281.70% | -286.49% | -275.38% | -506.82% |
| Operating Income | -23.61M | -19.10M | -12.66M | -12.00M | -14.05M | -19.21M | -21.99M | -30.44M |
| Operating Income Ratio | -170.43% | -346.62% | -212.12% | -273.25% | -288.28% | -293.57% | -283.66% | -518.67% |
| Total Other Income/Expenses | 1.47M | 0.00 | 13.00K | -921.00K | -1.50M | -2.47M | -2.61M | -2.06M |
| Income Before Tax | -22.15M | -19.10M | -12.64M | -12.93M | -15.54M | -21.68M | -24.60M | -32.50M |
| Income Before Tax Ratio | -159.85% | -346.62% | -211.90% | -294.22% | -318.98% | -331.25% | -317.27% | -553.76% |
| Income Tax Expense | -12.00K | 467.00K | 94.00K | 51.00K | 7.00K | -5.00K | 119.00K | 3.00K |
| Net Income | -22.13M | -19.57M | -12.74M | -12.98M | -15.55M | -21.68M | -24.72M | -32.50M |
| Net Income Ratio | -159.76% | -355.09% | -213.48% | -295.38% | -319.13% | -331.17% | -318.81% | -553.81% |
| EPS | -2.59 | -2.20 | -1.86 | -5.74 | -18.90 | -103.04 | -213.98 | -431.63 |
| EPS Diluted | -2.59 | -2.20 | -1.86 | -5.74 | -18.90 | -103.04 | -213.98 | -431.63 |
| Weighted Avg Shares Out | 8.53M | 8.91M | 6.85M | 2.25M | 823.33K | 210.36K | 115.51K | 75.30K |
| Weighted Avg Shares Out (Dil) | 8.53M | 8.91M | 6.85M | 2.25M | 823.33K | 210.36K | 115.51K | 75.30K |
ReWalk Robotics: The Next Phase Hinges On Medicare
ReWalk Robotics Ltd. (RWLK) Q4 2022 Earnings Call Transcript
ReWalk Robotics Ltd. (RWLK) Q3 2022 Earnings Call Transcript
ReWalk Robotics (RWLK) Reports Q3 Loss, Lags Revenue Estimates
ReWalk Robotics to Report Third Quarter 2022 Financial Results on November 7, 2022
ReWalk Robotics to Report Second Quarter 2022 Financial Results on August 9, 2022
10 Top Penny Stocks To Buy In June According To These Insiders Part 1
ReWalk Robotics Ltd. (RWLK) CEO Larry Jasinki on Q1 2022 Results - Earnings Call Transcript
ReWalk Robotics (RWLK) Reports Q1 Loss, Lags Revenue Estimates
ReWalk Robotics to Report First Quarter 2022 Financial Results on May 13, 2022
Source: https://incomestatements.info
Category: Stock Reports